ATM protects against oxidative stress induced by oxidized low-density lipoprotein

DNA Repair

Volumn 10, Issue 8, 2011, Pages 848-860

  Semlitsch, Michaela ^a   Shackelford, Rodney E ^b   Zirkl, Sandra ^a   Sattler, Wolfgang ^a   Malle, Ernst ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Atherosclerosis; Colony forming efficiency assay; DNA double strand breaks; EA.hy926 cells; Hydrogen peroxide; Modified LDL; P21; ROS

Indexed keywords

AMMONIUM PYRROLIDINE DITHIOCARBAMATE; ANTIOXIDANT; ATM PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; PROTEIN P21; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ARTICLE; ATAXIA TELANGIECTASIA; ATHEROSCLEROSIS; CELL PROTECTION; CELL VIABILITY; CHROMOSOME BREAKAGE; CYTOTOXICITY; DNA DAMAGE; DOUBLE STRANDED DNA BREAK; ENDOTHELIUM CELL; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MACROPHAGE; MICRONUCLEUS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; WESTERN BLOTTING;

ANTIOXIDANTS; CELL CYCLE PROTEINS; CELL LINE; CELL SURVIVAL; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA BREAKS, DOUBLE-STRANDED; DNA-BINDING PROTEINS; ENDOTHELIAL CELLS; FIBROBLASTS; GENE EXPRESSION; HUMANS; LIPOPROTEINS, LDL; OXIDATIVE STRESS; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEIN-SERINE-THREONINE KINASES; PYRROLIDINES; REACTIVE OXYGEN SPECIES; THIOCARBAMATES; TUMOR SUPPRESSOR PROTEINS;

ATAXIA TELANGIECTASIA;

EID: 79960699411     PISSN: 15687864     EISSN: 15687856     Source Type: Journal    
DOI: 10.1016/j.dnarep.2011.05.004     Document Type: Article

References (76)

1. Dröge W. Free radicals in the physiological control of cell function. Physiol. Rev. 2002, 82:47-95.
2. Thannickal V.J., Fanburg B.L. Reactive oxygen species in cell signaling. Am. J. Physiol. Lung Cell. Mol. Physiol. 2000, 279:L1005-1028.
3. Trachootham D., Lu W., Ogasawara M.A., Nilsa R.D., Huang P. Redox regulation of cell survival. Antioxid. Redox Signal. 2008, 10:1343-1374.
4. Miura Y., Endo T. Survival responses to oxidative stress and aging. Geriatr. Gerontol. Int. 2010, 10(Suppl. 1):S1-S9.
5. McKinnon P.J. ATM and ataxia telangiectasia. EMBO Rep. 2004, 5:772-776.
6. Lavin M.F. Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer. Nat. Rev. Mol. Cell Biol. 2008, 9:759-769.
7. Barzilai A., Rotman G., Shiloh Y. ATM deficiency and oxidative stress: a new dimension of defective response to DNA damage. DNA Repair (Amst.) 2002, 1:3-25.
8. Bakkenist C.J., Kastan M.B. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 2003, 421:499-506.
9. Kurz E.U., Lees-Miller S.P. DNA damage-induced activation of ATM and ATM-dependent signaling pathways. DNA Repair (Amst.) 2004, 3:889-900.
10. Shiloh Y. The ATM-mediated DNA-damage response: taking shape. Trends Biochem. Sci. 2006, 31:402-410.
11. Watters D.J. Oxidative stress in ataxia telangiectasia. Redox Rep. 2003, 8:23-29.
12. Reichenbach J., Schubert R., Schwan C., Muller K., Bohles H.J., Zielen S. Anti-oxidative capacity in patients with ataxia telangiectasia. Clin. Exp. Immunol. 1999, 117:535-539.
13. Schubert R., Erker L., Barlow C., Yakushiji H., Larson D., Russo A., Mitchell J.B., Wynshaw-Boris A. Cancer chemoprevention by the antioxidant tempol in Atm-deficient mice. Hum. Mol. Genet. 2004, 13:1793-1802.
14. Reliene R., Schiestl R.H. Antioxidants suppress lymphoma and increase longevity in Atm-deficient mice. J. Nutr. 2007, 137:229S-232S.
15. Zhan H., Suzuki T., Aizawa K., Miyagawa K., Nagai R. Ataxia telangiectasia mutated (ATM)-mediated DNA damage response in oxidative stress-induced vascular endothelial cell senescence. J. Biol. Chem. 2010, 285:29662-29670.
16. Shackelford R.E., Innes C.L., Sieber S.O., Heinloth A.N., Leadon S.A., Paules R.S. The Ataxia telangiectasia gene product is required for oxidative stress-induced G1 and G2 checkpoint function in human fibroblasts. J. Biol. Chem. 2001, 276:21951-21959.
17. Guo Z., Kozlov S., Lavin M.F., Person M.D., Paull T.T. ATM activation by oxidative stress. Science 2010, 330:517-521.
18. Valko M., Leibfritz D., Moncol J., Cronin M.T., Mazur M., Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 2007, 39:44-84.
19. Stocker R., Keaney J.F. Role of oxidative modifications in atherosclerosis. Physiol. Rev. 2004, 84:1381-1478.
20. Lusis A.J. Atherosclerosis. Nature 2000, 407:233-241.
21. Su Y., Swift M. Mortality rates among carriers of ataxia-telangiectasia mutant alleles. Ann. Intern. Med. 2000, 133:770-778.
22. Wu D., Yang H., Xiang W., Zhou L., Shi M., Julies G., Laplante J.M., Ballard B.R., Guo Z. Heterozygous mutation of ataxia-telangiectasia mutated gene aggravates hypercholesterolemia in apoE-deficient mice. J. Lipid Res. 2005, 46:1380-1387.
23. Mercer J.R., Cheng K.K., Figg N., Gorenne I., Mahmoudi M., Griffin J., Vidal-Puig A., Logan A., Murphy M.P., Bennett M. DNA damage links mitochondrial dysfunction to atherosclerosis and the metabolic syndrome. Circ. Res. 2010, 107:1021-1031.
24. Schneider J.G., Finck B.N., Ren J., Standley K.N., Takagi M., Maclean K.H., Bernal-Mizrachi C., Muslin A.J., Kastan M.B., Semenkovich C.F. ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome. Cell. Metab. 2006, 4:377-389.
25. Esterbauer H., Gebicki J., Puhl H., Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic. Biol. Med. 1992, 13:341-390.
26. Ziv Y., Jaspers N.G., Etkin S., Danieli T., Trakhtenbrot L., Amiel A., Ravia Y., Shiloh Y. Cellular and molecular characteristics of an immortalized ataxia-telangiectasia (group AB) cell line. Cancer Res. 1989, 49:2495-2501.
27. Rossmann C., Rauh A., Hammer A., Windischhofer W., Zirkl S., Sattler W., Malle E. Hypochlorite-modified high-density lipoprotein promotes induction of HO-1 in endothelial cells via activation of p42/44 MAPK and zinc finger transcription factor Egr-1. Arch. Biochem. Biophys. 2011, 509:16-25.
28. Porubsky S., Schmid H., Bonrouhi M., Kretzler M., Malle E., Nelson P.J., Grone H.J. Influence of native and hypochlorite-modified low-density lipoprotein on gene expression in human proximal tubular epithelium. Am. J. Pathol. 2004, 164:2175-2187.
29. Malle E., Ibovnik A., Steinmetz A., Kostner G.M., Sattler W. Identification of glycoprotein IIb as the lipoprotein(a)-binding protein on platelets. Lipoprotein(a) binding is independent of an arginyl-glycyl-aspartate tripeptide located in apolipoprotein(a). Arterioscler. Thromb. 1994, 14:345-352.
30. Malle E., Hazell L., Stocker R., Sattler W., Esterbauer H., Waeg G. Immunologic detection and measurement of hypochlorite-modified LDL with specific monoclonal antibodies. Arterioscler. Thromb. Vasc. Biol. 1995, 15:982-989.
31. Hickson I., Zhao Y., Richardson C.J., Green S.J., Martin N.M., Orr A.I., Reaper P.M., Jackson S.P., Curtin N.J., Smith G.C. Identification and characterization of a novel and specific inhibitor of the ataxia-telangiectasia mutated kinase ATM. Cancer Res. 2004, 64:9152-9159.
32. Rauh A., Windischhofer W., Kovacevic A., DeVaney T., Huber E., Semlitsch M., Leis H.J., Sattler W., Malle E. Endothelin (ET)-1 and ET-3 promote expression of c-fos and c-jun in human choriocarcinoma via ET(B) receptor-mediated G(i)- and G(q)-pathways and MAP kinase activation. Br. J. Pharmacol. 2008, 154:13-24.
33. Egger T., Schuligoi R., Wintersperger A., Amann R., Malle E., Sattler W. Vitamin E (alpha-tocopherol) attenuates cyclo-oxygenase 2 transcription and synthesis in immortalized murine BV-2 microglia. Biochem. J. 2003, 370:459-467.
34. Fenech M. The in vitro micronucleus technique. Mutat. Res. 2000, 455:81-95.
35. Kirsch-Volders M., Sofuni T., Aardema M., Albertini S., Eastmond D., Fenech M., Ishidate M., Lorge E., Norppa H., Surralles J., von der Hude W., Wakata A. Report from the In Vitro Micronucleus Assay Working Group. Environ. Mol. Mutagen. 2000, 35:167-172.
36. Shackelford R.E., Fu Y., Manuszak R.P., Brooks T.C., Sequeira A.P., Wang S., Lowery-Nordberg M., Chen A. Iron chelators reduce chromosomal breaks in ataxia-telangiectasia cells. DNA Repair (Amst.) 2006, 5:1327-1336.
37. Kitz K., Windischhofer W., Leis H.J., Huber E., Kollroser M., Malle E. 15-Deoxy-delta12,14-prostaglandin J2 induces Cox-2 expression in human osteosarcoma cells through MAPK and EGFR activation involving reactive oxygen species. Free Radic. Biol. Med. 2011, 50:854-865.
38. Shackelford R.E., Manuszak R.P., Johnson C.D., Hellrung D.J., Link C.J., Wang S. Iron chelators increase the resistance of Ataxia telangeictasia cells to oxidative stress. DNA Repair (Amst.) 2004, 3:1263-1272.
39. Wei F., Xie Y., Tao L., Tang D. Both ERK1 and ERK2 kinases promote G2/M arrest in etoposide-treated MCF7 cells by facilitating ATM activation. Cell. Signal. 2010, 22:1783-1789.
40. Zhao H., Tanaka T., Mitlitski V., Heeter J., Balazs E.A., Darzynkiewicz Z. Protective effect of hyaluronate on oxidative DNA damage in WI-38 and A549 cells. Int. J. Oncol. 2008, 32:1159-1167.
41. Wang X., McGowan C.H., Zhao M., He L., Downey J.S., Fearns C., Wang Y., Huang S., Han J. Involvement of the MKK6-p38gamma cascade in gamma-radiation-induced cell cycle arrest. Mol. Cell. Biol. 2000, 20:4543-4552.
42. Lavin M.F., Birrell G., Chen P., Kozlov S., Scott S., Gueven N. ATM signaling and genomic stability in response to DNA damage. Mutat. Res. 2005, 569:123-132.
43. Slater T.F., Sawyer B., Straeuli U. Studies on succinate-tetrazolium reductase systems. III. Points of coupling of four different tetrazolium salts. Biochim. Biophys. Acta 1963, 77:383-393.
44. Rogakou E.P., Pilch D.R., Orr A.H., Ivanova V.S., Bonner W.M. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J. Biol. Chem. 1998, 273:5858-5868.
45. Watters G.P., Smart D.J., Harvey J.S., Austin C.A. H2AX phosphorylation as a genotoxicity endpoint. Mutat. Res. 2009, 679:50-58.
46. Reichenbach J., Schubert R., Schindler D., Muller K., Bohles H., Zielen S. Elevated oxidative stress in patients with ataxia telangiectasia. Antioxid. Redox Signal. 2002, 4:465-469.
47. Zhu B.Z., Carr A.C., Frei B. Pyrrolidine dithiocarbamate is a potent antioxidant against hypochlorous acid-induced protein damage. FEBS Lett. 2002, 532:80-84.
48. Gehen S.C., Staversky R.J., Bambara R.A., Keng P.C., O'Reilly M.A. hSMG-1 and ATM sequentially and independently regulate the G1 checkpoint during oxidative stress. Oncogene 2008, 27:4065-4074.
49. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat. Rev. Cancer 2003, 3:155-168.
50. Ambrose M., Goldstine J.V., Gatti R.A. Intrinsic mitochondrial dysfunction in ATM-deficient lymphoblastoid cells. Hum. Mol. Genet. 2007, 16:2154-2164.
51. Fu X., Wan S., Lyu Y.L., Liu L.F., Qi H. Etoposide induces ATM-dependent mitochondrial biogenesis through AMPK activation. PLoS One 2008, 3:e2009.
52. Steinberg D., Lewis A. Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis. Circulation 1997, 95:1062-1071.
53. Steinbrecher U.P., Zhang H.F., Lougheed M. Role of oxidatively modified LDL in atherosclerosis. Free Radic. Biol. Med. 1990, 9:155-168.
54. Maier J.A., Barenghi L., Bradamante S., Pagani F. Induction of human endothelial cell growth by mildly oxidized low density lipoprotein. Atherosclerosis 1996, 123:115-121.
55. Chai Y.C., Howe P.H., DiCorleto P.E., Chisolm G.M. Oxidized low density lipoprotein and lysophosphatidylcholine stimulate cell cycle entry in vascular smooth muscle cells. Evidence for release of fibroblast growth factor-2. J. Biol. Chem. 1996, 271:17791-17797.
56. Chatterjee S., Ghosh N. Oxidized low density lipoprotein stimulates aortic smooth muscle cell proliferation. Glycobiology 1996, 6:303-311.
57. Hamilton J.A., Myers D., Jessup W., Cochrane F., Byrne R., Whitty G., Moss S. Oxidized LDL can induce macrophage survival, DNA synthesis, and enhanced proliferative response to CSF-1 and GM-CSF. Arterioscler. Thromb. Vasc. Biol. 1999, 19:98-105.
58. Matsuura E., Kobayashi K., Tabuchi M., Lopez L.R. Oxidative modification of low-density lipoprotein and immune regulation of atherosclerosis. Prog. Lipid Res. 2006, 45:466-486.
59. Maziere C., Maziere J.C. Activation of transcription factors and gene expression by oxidized low-density lipoprotein. Free Radic. Biol. Med. 2009, 46:127-137.
60. Green M.H., Marcovitch A.J., Harcourt S.A., Lowe J.E., Green I.C., Arlett C.F. Hypersensitivity of ataxia-telangiectasia fibroblasts to a nitric oxide donor. Free Radic. Biol. Med. 1997, 22:343-347.
61. Shackelford R.E., Kaufmann W.K., Paules R.S. Cell cycle control, checkpoint mechanisms, and genotoxic stress. Environ. Health Perspect. 1999, 107(Suppl. 1):5-24.
62. Dickey J.S., Redon C.E., Nakamura A.J., Baird B.J., Sedelnikova O.A., Bonner W.M. H2AX: functional roles and potential applications. Chromosoma 2009, 118:683-692.
63. Burma S., Chen B.P., Murphy M., Kurimasa A., Chen D.J. ATM phosphorylates histone H2AX in response to DNA double-strand breaks. J. Biol. Chem. 2001, 276:42462-42467.
64. Ward I.M., Chen J. Histone H2AX is phosphorylated in an ATR-dependent manner in response to replicational stress. J. Biol. Chem. 2001, 276:47759-47762.
65. Stiff T., O'Driscoll M., Rief N., Iwabuchi K., Lobrich M., Jeggo P.A. ATM and DNA-PK function redundantly to phosphorylate H2AX after exposure to ionizing radiation. Cancer Res. 2004, 64:2390-2396.
66. Lavin M.F., Kozlov S. ATM activation and DNA damage response. Cell Cycle 2007, 6:931-942.
67. Yan M., Zhu C., Liu N., Jiang Y., Scofield V.L., Riggs P.K., Qiang W., Lynn W.S., Wong P.K. ATM controls c-Myc and DNA synthesis during postnatal thymocyte development through regulation of redox state. Free Radic. Biol. Med. 2006, 41:640-648.
68. Barlow C., Dennery P.A., Shigenaga M.K., Smith M.A., Morrow J.D., Roberts L.J., Wynshaw-Boris A., Levine R.L. Loss of the ataxia-telangiectasia gene product causes oxidative damage in target organs. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:9915-9919.
69. Ito K., Hirao A., Arai F., Matsuoka S., Takubo K., Hamaguchi I., Nomiyama K., Hosokawa K., Sakurada K., Nakagata N., Ikeda Y., Mak T.W., Suda T. Regulation of oxidative stress by ATM is required for self-renewal of haematopoietic stem cells. Nature 2004, 431:997-1002.
70. Nasrin N., Mimish L.A., Manogaran P.S., Kunhi M., Sigut D., Al-Sedairy S., Hannan M.A. Cellular radiosensitivity, radioresistant DNA synthesis, and defect in radioinduction of p53 in fibroblasts from atherosclerosis patients. Arterioscler. Thromb. Vasc. Biol. 1997, 17:947-953.
71. Alexander A., Cai S.L., Kim J., Nanez A., Sahin M., MacLean K.H., Inoki K., Guan K.L., Shen J., Person M.D., Kusewitt D., Mills G.B., Kastan M.B., Walker C.L. ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:4153-4158.
72. Reliene R., Fleming S.M., Chesselet M.F., Schiestl R.H. Effects of antioxidants on cancer prevention and neuromotor performance in Atm deficient mice. Food Chem. Toxicol. 2008, 46:1371-1377.
73. Moellering D., McAndrew J., Jo H., Darley-Usmar V.M. Effects of pyrrolidine dithiocarbamate on endothelial cells: protection against oxidative stress. Free Radic. Biol. Med. 1999, 26:1138-1145.
74. Schreck R., Meier B., Mannel D.N., Droge W., Baeuerle P.A. Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J. Exp. Med. 1992, 175:1181-1194.
75. Qin K., Zhao L., Ash R.D., McDonough W.F., Zhao R.Y. ATM-mediated transcriptional elevation of prion in response to copper-induced oxidative stress. J. Biol. Chem. 2009, 284:4582-4593.
76. Zha S., Sekiguchi J., Brush J.W., Bassing C.H., Alt F.W. Complementary functions of ATM and H2AX in development and suppression of genomic instability. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:9302-9306.